What Celoxica does

Celoxica is a UK-headquartered, privately-held vendor of FPGA-based ultra-low latency trading infrastructure serving the global capital markets electronic-trading community. Its platform is composed of three integrated core products: QDS (FPGA-based feed handlers delivering normalised market data with instrument filtering, line arbitrage, and full depth-of-book reconstruction), MAG (an in-line pre-trade risk management and DMA platform offering single-digit microsecond FIX latency, hundreds-of-nanoseconds Native latency, and 15-C3 / MiFID II compliance), and GXA (venue gateways providing normalised APIs, session management, load balancing, and TCP Direct order execution). Together they form a full tick-to-trade stack covering market data ingestion, risk controls, and order routing across equities, futures, options, and fixed income, supported at over 60 exchanges, brokers, and liquidity venues worldwide.

The company serves two primary customer segments — buy-side firms (hedge funds, quantitative traders, proprietary trading firms) and sell-side institutions (banks and brokers) — through a direct enterprise field-sales motion with regional coverage in London (HQ), New York (Americas), Sydney (APAC), and Paris (engineering). Revenue is generated via managed-service engagements delivered in co-located hosting environments, encompassing implementation, onboarding, EDC support, and ongoing platform monitoring, alongside recurring platform access for MAG, GXA, and QDS. Pricing is quote-based and not publicly disclosed. Celoxica is ISO 27001 certified, won the TradingTech Insight Awards Europe 2026 "Best Pre-trade Risk Provider" recognition, and is led by an executive team drawn from Instinet, Merrill Lynch, Goldman Sachs, Deutsche Bank, Morgan Stanley, NYSE Euronext, and Reuters.

Name

Celoxica

Legal name

Celoxica Limited

Website

https://celoxica.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

Celoxica provides FPGA-based ultra-low latency market data (QDS), pre-trade risk and DMA (MAG), and order execution gateways (GXA) as an integrated tick-to-trade platform for global hedge funds, proprietary traders, and sell-side banks and brokers.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Managed Trading Infrastructure Services: Full-service ULL trading solutions including low-latency products, associated infrastructure services, implementation, client onboarding, system upgrades, EDCs, and platform monitoring. Revenue generated through managed services delivered in fully hosted, co-located environments.
2. Technology Licensing and Platform Access: Access to MAG risk management platform, GXA execution gateways, and QDS market data products, provided as integrated solutions rather than standalone products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Celoxica provides an integrated ultra-low latency trading platform comprising three products — QDS market data feed handlers, MAG pre-trade risk management and direct market access, and GXA order execution gateways — delivered as a full-service, co-located managed trading stack for buy-side and sell-side systematic trading clients across global equities, derivatives and fixed income markets.

Product overview

Celoxica provides a unified platform of three integrated core products for ultra-low latency trading: MAG (Pre-trade Risk Management and DMA), GXA (Gateways/Order Execution), and QDS (Market Data/Feed Handlers). These products work together to deliver a full-service trading solution from tick to trade, supporting the complete systematic trading lifecycle across market data, risk management, and order execution for buy and sell side clients globally.

Differentiator

Problem solved

Functional benefit

Brands

• MAG: Pre-trade risk management and DMA platform providing ultra-low latency risk and execution services with extensive operational management, GUI front end, Drop Copy interface, API risk integration, and full monitoring services.
• GXA
• QDS

Products and services

• MAG (Pre-trade Risk Management and DMA) In-Line Risk Management and Order Execution platform providing ultra-low latency pre-trade risk controls and direct market access for brokers and buy-side trading firms across multiple asset classes including futures, equities, rates and options. Supports single-digit wire-to-wire latency for FIX, hundreds of nanoseconds for Native protocols, EDC support, high availability, and full compliance with 15-C3 and MiFID II.
• GXA (Gateways, Order Execution) Accelerated Order Entry solutions providing deterministic performance across a wide range of exchanges and trading venues via a normalised API supporting multiple asset classes, session management, order balancing, FIX parsing, TCP Direct connectivity and full recovery.
• QDS (Ultra Low Latency Market Data) FPGA-based Feed Handler technology delivering normalised market data with instrument filtering, line arbitrage, full depth order books, normalisation, fully automated recovery and multi-channel DMA, deployed on the same server as client trading strategies via a C++ API to produce deterministic ultra-low latency performance.

Quantifiable outcome

• Single-digit wire-to-wire latency for FIX and hundreds of nanoseconds for Native protocols
• +2 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• SS&C Eze: Order management and execution platform widely used by hedge funds and asset managers. Adjacent competitor for trading workflow layer where Celoxica's clients sit.
• ION Group: Large capital markets technology provider with multiple trading, risk, and connectivity products. Sells into the same bank and broker buyers Celoxica targets, often as bundled offering.
• Enfusion (now Clearwater Analytics): Cloud-native investment management platform including order/EMS capabilities; competes adjacent to Celoxica in serving the same hedge fund and prop trading buyer base, though with software rather than FPGA architecture.
• Itiviti (now Broadridge): Broad post-trade and connectivity platform for capital markets, including low-latency order routing and FIX gateways. Larger incumbent with broader portfolio, competing in execution gateway and connectivity tiers.
• FIS (Fidelity National Information Services): Global capital markets technology vendor offering trading, risk, and post-trade infrastructure. Larger incumbent that competes in execution, risk, and market data tiers served by Celoxica.

Direct peers

• Options IT: Provides ultra-low latency pre-trade risk management and order routing technology for derivatives and equities markets. Competes head-to-head with Celoxica's MAG and GXA products in the broker and exchange space.
• NovaSparks: FPGA-based market data normalization and order execution for equities and derivatives. Direct technology competitor in FPGA feed handling and execution, serving similar buy-side and sell-side clients.
• Algo-Logic Systems: FPGA-accelerated trading solutions including feed handlers, pre-trade risk, and execution for global exchanges. Direct technology peer competing on the same FPGA deterministic-latency value proposition.
• Exegy: Provider of FPGA-accelerated market data feed handlers, pre-trade risk, and execution gateways for global capital markets. Closest direct competitor to Celoxica's QDS/MAG/GXA stack, now part of FactSet.
• Redline Trading Solutions: Ultra-low latency market data and order execution platform designed for systematic trading firms. Direct competitor in co-located feed handling and execution gateway products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/celoxica
• Xx.com/Celoxica

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds9 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celoxica